Carregant...
Effect of a daily dose of Lactobacillus brevis CD2 lozenges in high caries risk schoolchildren
OBJECTIVES: A double-blind, randomised, placebo-controlled clinical trial was performed to validate the hypothesis that the use of lozenges containing Lactobacillus brevis CD2 (Inersan®, CD Investments srl) may reduce plaque pH, salivary mutans streptococci (ms) and bleeding on probing, during a 6-w...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Berlin Heidelberg
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3936134/ https://ncbi.nlm.nih.gov/pubmed/23644602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00784-013-0980-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|